BELLUCCI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 5.821
EU - Europa 3.762
AS - Asia 2.073
SA - Sud America 191
Continente sconosciuto - Info sul continente non disponibili 76
AF - Africa 43
OC - Oceania 31
Totale 11.997
Nazione #
US - Stati Uniti d'America 5.730
RU - Federazione Russa 995
PL - Polonia 936
IT - Italia 643
SG - Singapore 602
CN - Cina 437
HK - Hong Kong 331
VN - Vietnam 309
SE - Svezia 287
IE - Irlanda 279
KR - Corea 155
BR - Brasile 151
DE - Germania 143
UA - Ucraina 121
FI - Finlandia 114
FR - Francia 86
GB - Regno Unito 83
IN - India 72
CA - Canada 50
JP - Giappone 45
AU - Australia 31
MX - Messico 22
ID - Indonesia 18
JO - Giordania 16
AR - Argentina 15
BD - Bangladesh 14
ES - Italia 13
NL - Olanda 13
IQ - Iraq 12
TR - Turchia 12
BE - Belgio 11
CI - Costa d'Avorio 11
CH - Svizzera 10
CL - Cile 7
NG - Nigeria 7
NP - Nepal 6
RO - Romania 6
CO - Colombia 5
PK - Pakistan 5
SA - Arabia Saudita 5
SC - Seychelles 5
AZ - Azerbaigian 4
EC - Ecuador 4
GT - Guatemala 4
HR - Croazia 4
KE - Kenya 4
PH - Filippine 4
VE - Venezuela 4
ZA - Sudafrica 4
EG - Egitto 3
HU - Ungheria 3
IL - Israele 3
JM - Giamaica 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
PY - Paraguay 3
TH - Thailandia 3
AT - Austria 2
CR - Costa Rica 2
CY - Cipro 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GP - Guadalupe 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MY - Malesia 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SN - Senegal 1
SV - El Salvador 1
SX - ???statistics.table.value.countryCode.SX??? 1
VG - Isole Vergini Britanniche 1
Totale 11.923
Città #
Santa Clara 1.060
Warsaw 930
Ashburn 880
Singapore 430
Fairfield 321
Chandler 301
Dublin 278
Hong Kong 273
San Jose 198
Woodbridge 191
Jacksonville 172
Seattle 156
Cambridge 155
Seoul 153
Houston 151
Wilmington 132
Council Bluffs 124
Dong Ket 124
Milan 119
Beijing 103
Buffalo 101
Ann Arbor 92
Los Angeles 91
Princeton 69
Ho Chi Minh City 68
The Dalles 68
Boston 66
Rome 62
Altamura 55
Lauterbourg 53
Mumbai 52
Florence 49
Hefei 45
Tokyo 44
Dallas 43
Lawrence 41
Boardman 40
Hanoi 34
Munich 33
New York 33
Melbourne 31
Phoenix 30
Helsinki 28
Chicago 26
Moscow 24
Shanghai 23
Turku 21
Falls Church 20
Guangzhou 20
Kent 20
Medford 20
Norwalk 17
Turin 17
Orem 16
Redondo Beach 16
Paris 15
San Diego 15
Toronto 15
Washington 14
Bari 13
Denver 13
São Paulo 13
Bologna 12
Frankfurt am Main 12
Verona 12
West Jordan 12
Abidjan 11
Brussels 11
Columbus 11
Montreal 11
Naples 11
Dearborn 10
Hillsboro 10
Philadelphia 10
Bern 9
Haiphong 9
Jakarta 9
London 9
Atlanta 8
Clifton 8
Da Nang 8
Figino 8
Genoa 8
San Francisco 8
Barcelona 7
Yubileyny 7
Abuja 6
Amman 6
Andover 6
Brooklyn 6
Charlotte 6
Chennai 6
Curitiba 6
Frankfurt Am Main 6
Las Vegas 6
Baghdad 5
Birmingham 5
Lappeenranta 5
Mexico City 5
Palermo 5
Totale 8.127
Nome #
Antinociceptive property of the nicotinic agonist AG4 in rodents 537
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 348
Antisense knockdowns of M1 receptors induces transient anterograde amnesia in mice 344
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 316
Antinociceptive and antiamnesic properties of the presynaptic amplifier PG-9 308
Memory facilitation with atropine: a paradoxical effect 306
In vitro characterization of a novel, potent and selective M3 antagonist 295
MOLECULAR MODULATION OF MUSCARINIC ANTAGONISTS. SYNTHESIS AND AFFINITY PROFILE OF 2,2-DIPHENYL-2-ETHYLTHIO-ACETIC ACID ESTERS DESIGNED TO PROBE THE BINDING SITE CAVITY 268
New Rigid Nicotine Analogues, Carrying a Norbornane Moiety, Are Potent Agonists of α7 and α3∗ Nicotinic Receptors 257
(1,3-Dioxolane)- and (1,3-oxathiolane)-2-pyrrolidines: molecular hybrids with potential anti-Alzheimer activity 240
Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters 238
Antagonisti muscarinici a struttura 1,3-ossatiolano-2-pirrolidinica 228
1,4-Diazabicyclo[4.3.0]nonan-9-ones and 1,4-diamidopiperazines as new classes of highly potent nootropic drugs 221
New structure–activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR) 217
FURTHER STRUCTURE-ACTIVITY RELATIONSHIPS IN THE SERIES OF TROPANYL ESTERS ENDOWED WITH POTENT ANTINOCICEPTIVE ACTIVITY 216
SYNTHESIS, AFFINITY PROFILE AND FUNCTIONAL ACTIVITY OF MUSCARINIC ANTAGONISTS WITH A 1-METHYL-2-(2,2-ALKYLARYL-1,3-OXATHIOLAN-5-YL)PYRROLIDINE STRUCTURE 216
Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist. 211
Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities 210
Carbachol dimers as homobivalent modulators of muscarinic receptors 208
ANALGESIC, ANTIMUSCARINIC ACTIVITY AND ENANTIOSELECTIVITY OF THE FOUR ISOMERS OF 3-QUINUCLIDINYL TROPATE AS COMPARED WITH THE ENANTIOMERS OF HYOSCYAMINE 203
1,4-Diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs 196
Synthesis and Cholinergic Affinity of Diastereomeric and Enantiomeric Isomers of 1-Methyl-2-(2-methyl-1,3-dioxolan-4-yl)-pyrrolidine, 1-Methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine and of Their Iodomethylates 195
Muscarinic antagonists with multiple stereocenters: synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives 184
SYNTHESIS, CHARACTERIZATION AND PHARMACOLOGICAL PROFILE OF TROPICAMIDE ENANTIOMERS 180
DIFFERENTIAL ANALGESIC ACTIVITY OF THE ENANTIOMERS OF ATROPINE DERIVATIVES DOES NOT CORRELATE WITH THEIR MUSCARINIC SUBTYPE SELECTIVITY 180
Attività analgesica e antimuscarinica ed enantioselettività dei quattro isomeri del tropato del 3-chinuclidinolo messe a confronto con gli enantiomeri della iosciamina 179
Carbachol dimers with primary carbamate groups as homobivalent modulators of muscarinic receptors 179
MOLECULAR MODULATION OF MUSCARINIC ANTAGONISTS. SYNTHESIS AND PHARMACOLOGICAL PROFILE OF 2,2-DIPHENYL-2-ETHYLTHIOACETIC AND 3,3-DIPHENYL-3-ETHYLTHIOPROPIONIC ACID DERIVATIVES CHARACTERIZED BY A DIPEPTIDE SPACER 178
Modulazione molecolare di antagonisti muscarinici. Sintesi e valutazione farmacologica preliminare di esteri amminoalchil piperazinici e piperidinici dell'acido 2,2-difenil-2-etiltioacetico 175
Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives. 168
Muscarine-like compounds derived from a pyrolysis product of cellulose 168
New multidrug resistance (MDR) agents endowed with good potency and efficacy 163
Design, synthesis and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain 162
New insights in the metabolism of Oxybutynin: evidence of N-oxidation of propargylamine moiety and rearrangement to enaminoketone 161
Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists 160
Structure-activity relationships in 2,2-diphenyl-2-ethylthioacetic acid esters: unexpected agonistic activity in a series of muscarinic antagonists. 157
Differential analgesic activity of the enantiomers of atropine derivatives does not correlate with their muscarinic subtype selectivity 157
Synthesis, Affinity Profile and Functional Activity of Potent Chiral Muscarinic Antagonists with a Pyrrolidinylfuran Structure 155
New N-alkanol-N-cyclohexanolamine aryl ester derivatives as reverting agents of Multidrug Resistance (MDR) 153
Sintesi e valutazione farmacologica di derivati furanici e tetraidrofuranici a potenziale azione muscarinica 152
New potent piperazine and aminopiperidine derivatives as reverting agents of Multidrug Resistance (MDR) 149
Flavonoid aminoesters acting as reversing agents of Pgp-dependent multidrug resistance (MDR) 149
NEGATIVE INOTROPIC ACTIVITY OF PARA-SUBSTITUTED DIETHYL BENZYL PHOSPHONATES RELATED TO FOSTEDIL 148
Highly chiral muscarinic ligands: synthesis and affinity of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-oxathiolane-5-yl)pyrrolidine 3-sulfoxides and their methyl iodides 144
Antinociceptive and antiamnesic properties of the nicotinic agonist AG-4 143
New quinoline derivatives as nicotinic receptor modulators 142
NEGATIVE INOTROPIC AND CALCIUM ANTAGONISTIC ACTIVITY OF ALKYL AND ARYLALKYL PHOSPHONATES 138
synthesis, chiral HPLC separation and pharmacological characterization of muscarinic furan derivatives 136
Synthesis and pharmacological characterization of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-oxathiolane-5-yl)pyrrolidine 3-sulfoxides and their methyl iodides 136
Design, Synthesis and binding affinity of carbachol dimers as bitopic ligands 135
SEARCH FOR NEW CA2+ ANTAGONISTS. LIPOPHILIC OXIMES AND PHOSPHONATES 134
Hybridized and isosteric analogs of N1-acetyl-N4-dimethyl-piperazinium iodide (ADMP) and N1-phenyl-N4-dimethyl-piperazinium iodide (DMPP) with central nicotinic action 134
Design, Synthesis and binding affinity of new ligands for the central nicotinic receptors 131
SAR STUDIES IN THE FIELD OF CA2+ ANTAGONISTS. EFFECT OF MODIFICATIONS AT THE TETRASUBSTITUTED CARBON OF VERAPAMIL-LIKE COMPOUNDS 130
Molecular modulation of muscarinic antagonists. Synthesis and pharmacological profile of 2,2-diphenyl-2-ethylthioacetic acid and 3,3-diphenyl-3-ethylthiopropionic acid derivatives characterized by a dipeptide spacer 129
Design, synthesis and preliminary pharmacological evaluation of alkylderivatives of 4-aminopiperidine as N-type calcium channels blockers 127
New analogues of the potent nootropic drug DM235: 2-or 3-phenylpiperazines with limited conformational flexibility 122
Sintesi e affinità per i recettori colinergici degli stereoisomeri della 1-metil-2-(2-metil-1,3-diossolan-4-il)pirrolidina, della 1-metil-2-(2-metil-1,3-ossatiolan-5-il)pirrolidina e dei loro iodometilati 120
Unexpected Multidrug Resistance (MDR) reverting activity of a new series of N,N-bis(arylalkanol)amine aryl esters 117
Unexpected agonistic activity in a series of muscarinic antagonists 99
Piperazine derivatives possessing nootropic activity 97
Hybridized and isosteric analogs of N1-acetyl-N4-dimethylpiperazinium iodide (ADMP), N1-phenyl-N4-dimethylpiperazinium iodide (DMPP) with central nicotinic action 97
The double life of UNIFI nootropics 92
Progettazione, Sintesi e studio di molecular modeling di nuovi ligandi nicotinici 90
Hybridized and isosteric analogs of N1-acetyl-N4-dimethylpiperazinium iodide (ADMP), N1-phenyl-N4-dimethylpiperazinium iodide (DMPP) with central nicotinic action 90
Pharmacological profile of the enantiomers of tropicamide 79
Totale 11.997
Categoria #
all - tutte 31.091
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.091


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022339 0 0 0 13 16 19 28 12 15 18 87 131
2022/20231.201 113 180 53 96 84 232 170 72 127 12 42 20
2023/2024651 8 50 76 31 24 60 17 315 7 23 17 23
2024/20252.843 99 291 192 413 825 456 24 189 102 58 101 93
2025/20262.982 313 415 235 160 345 146 344 153 190 201 66 414
2026/2027741 180 108 386 67 0 0 0 0 0 0 0 0
Totale 11.997